Metoclopramide and Diphenhydramine: A Randomized Controlled Trial of a Treatment for Headache in Pregnancy when Acetaminophen Alone Is Ineffective (MAD Headache Study).
|
Childress KMS., Dothager C., Gavard JA., Lebovitz S., Laska C., Mostello DJ. |
2018 |
Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
|
Ephross SA., Sinclair SM. |
2014 |
Delivery outcome after maternal use of drugs for migraine: a register study in Sweden.
|
Källén B., Nilsson E., Otterblad Olausson P. |
2011 |
Acupuncture for tension-type headache in pregnancy: A prospective, randomized, controlled study
|
J.B. Guerreiro da Silva a, M.U. Nakamurab, J.A. Cordeiro a, L. Kulay b |
2012 |
Nonpharmacological management of headaches during pregnancy.
|
Marcus DA., Scharff L., Turk DC. |
1995 |
Nonpharmacological management of headaches during pregnancy.
|
Marcus DA., Scharff L., Turk DC. |
1995 |
Peripheral nerve blocks in the treatment of migraine in pregnancy.
|
Govindappagari S., Grossman TB., Dayal AK., Grosberg BM., Vollbracht S., Robbins MS. |
2014 |
Topiramate monotherapy use in women with and without epilepsy: pregnancy and neonatal outcomes.
|
Castilla-Puentes R., Ford L., Manera L., Kwarta RF., Ascher S., Li Q. |
2014 |
A non-pharmacological treatment of vascular headache during pregnancy.
|
Hickling EJ., Silverman DJ., Loos W. |
1990 |
Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study.
|
Spielmann K., Kayser A., Beck E., Meister R., Schaefer C. |
2018 |
Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study.
|
O'Quinn S., Ephross SA., Williams V., Davis RL., Gutterman DL., Fox AW. |
1999 |
Pregnancy outcome following prescription for sumatriptan.
|
Olesen C., Steffensen FH., Sorensen HT., Nielsen GL., Olsen J. |
2000 |
Pregnancy outcome following first trimester exposure to sumatriptan.
|
Shuhaiber S., Pastuszak A., Schick B., Matsui D., Spivey G., Brochu J., Koren G. |
1998 |
Triptan safety during pregnancy: a Norwegian population registry study.
|
Nezvalová-Henriksen K., Spigset O., Nordeng H. |
2013 |
Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study.
|
Nezvalová-Henriksen K., Spigset O., Nordeng H. |
2010 |
Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program.
|
Bhola R., Kinsella E., Giffin N., Lipscombe S., Ahmed F., Weatherall M., Goadsby PJ. |
2015 |
Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis.
|
McDonagh MS., Matthews A., Phillipi C., Romm J., Peterson K., Thakurta S., Guise JM. |
2014 |
Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis.
|
McDonagh MS., Matthews A., Phillipi C., Romm J., Peterson K., Thakurta S., Guise JM. |
2014 |
The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.
|
Yakoob MY., Bateman BT., Ho E., Hernandez-Diaz S., Franklin JM., Goodman JE., Hoban RA. |
2013 |
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.
|
Abalos E., Duley L., Steyn DW., Gialdini C. |
2018 |
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.
|
Abalos E., Duley L., Steyn DW., Gialdini C. |
2018 |
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
|
Bellos I., Pergialiotis V., Papapanagiotou A., Loutradis D., Daskalakis G. |
2020 |
Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
|
Veroniki AA., Cogo E., Rios P., Straus SE., Finkelstein Y., Kealey R., Reynen E., Soobiah C., Thavorn K., Hutton B., Hemmelgarn BR., Yazdi F., D'Souza J., MacDonald H., Tricco AC. |
2017 |
Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
|
Veroniki AA., Cogo E., Rios P., Straus SE., Finkelstein Y., Kealey R., Reynen E., Soobiah C., Thavorn K., Hutton B., Hemmelgarn BR., Yazdi F., D'Souza J., MacDonald H., Tricco AC. |
2017 |
Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
|
Veroniki AA., Cogo E., Rios P., Straus SE., Finkelstein Y., Kealey R., Reynen E., Soobiah C., Thavorn K., Hutton B., Hemmelgarn BR., Yazdi F., D'Souza J., MacDonald H., Tricco AC. |
2017 |
Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
|
Veroniki AA., Cogo E., Rios P., Straus SE., Finkelstein Y., Kealey R., Reynen E., Soobiah C., Thavorn K., Hutton B., Hemmelgarn BR., Yazdi F., D'Souza J., MacDonald H., Tricco AC. |
2017 |
Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
|
Veroniki AA., Cogo E., Rios P., Straus SE., Finkelstein Y., Kealey R., Reynen E., Soobiah C., Thavorn K., Hutton B., Hemmelgarn BR., Yazdi F., D'Souza J., MacDonald H., Tricco AC. |
2017 |
Safety of non-steroidal anti-inflammatory drugs in the postpartum period among women with hypertensive disorders of pregnancy: a meta-analysis.
|
Bellos I., Pergialiotis V., Antsaklis A., Loutradis D., Daskalakis G. |
2020 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
|
Henderson JT., Whitlock EP., O'Connor E., Senger CA., Thompson JH., Rowland MG. |
2014 |
Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review.
|
Coomarasamy A., Honest H., Papaioannou S., Gee H., Khan KS. |
2003 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
|
Duley L., Henderson-Smart DJ., Meher S., King JF. |
2007 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
|
Hamulyák EN., Scheres LJ., Marijnen MC., Goddijn M., Middeldorp S. |
2020 |
Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.
|
Maze D., Kazi S., Gupta V., Malinowski AK., Fazelzad R., Shah PS., Shehata N. |
2019 |
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.
|
Bain ES., Middleton PF., Crowther CA. |
2013 |
Magnesium supplementation in pregnancy.
|
Makrides M., Crosby DD., Bain E., Crowther CA. |
2014 |
The fetal safety of benzodiazepines: an updated meta-analysis.
|
Enato E., Moretti M., Koren G. |
2011 |
Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
|
Park-Wyllie L., Mazzotta P., Pastuszak A., Moretti ME., Beique L., Hunnisett L., Friesen MH., Jacobson S., Kasapinovic S., Chang D., Diav-Citrin O., Chitayat D., Nulman I., Einarson TR., Koren G. |
2000 |
The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis.
|
Etwel F., Faught LH., Rieder MJ., Koren G. |
2017 |
Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy.
|
Li CM., Zhernakova A., Engstrand L., Wijmenga C., Brusselaers N. |
2020 |
Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies.
|
Masarwa R., Levine H., Gorelik E., Reif S., Perlman A., Matok I. |
2018 |
Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis.
|
Hammers AL., Sanchez-Ramos L., Kaunitz AM. |
2015 |
Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
|
Chaemsaithong P., Cuenca-Gomez D., Plana MN., Gil MM., Poon LC. |
2020 |
Use of ondansetron during pregnancy and the risk of major congenital malformations: A systematic review and meta-analysis.
|
Kaplan YC., Richardson JL., Keskin-Arslan E., Erol-Coskun H., Kennedy D. |
2019 |
Risk of malformation after ondansetron in pregnancy: An updated systematic review and meta-analysis.
|
Picot C., Berard A., Grenet G., Ripoche E., Cucherat M., Cottin J. |
2020 |
Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.
|
Marchenko A., Etwel F., Olutunfese O., Nickel C., Koren G., Nulman I. |
2015 |
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy.
|
Coughlin CG., Blackwell KA., Bartley C., Hay M., Yonkers KA., Bloch MH. |
2015 |
Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis.
|
Terrana N., Koren G., Pivovarov J., Etwel F., Nulman I. |
2015 |
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
|
Weston J., Bromley R., Jackson CF., Adab N., Clayton-Smith J., Greenhalgh J., Hounsome J., McKay AJ., Tudur Smith C., Marson AG. |
2016 |
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
|
Weston J., Bromley R., Jackson CF., Adab N., Clayton-Smith J., Greenhalgh J., Hounsome J., McKay AJ., Tudur Smith C., Marson AG. |
2016 |
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
|
Weston J., Bromley R., Jackson CF., Adab N., Clayton-Smith J., Greenhalgh J., Hounsome J., McKay AJ., Tudur Smith C., Marson AG. |
2016 |
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
|
Weston J., Bromley R., Jackson CF., Adab N., Clayton-Smith J., Greenhalgh J., Hounsome J., McKay AJ., Tudur Smith C., Marson AG. |
2016 |
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
|
Weston J., Bromley R., Jackson CF., Adab N., Clayton-Smith J., Greenhalgh J., Hounsome J., McKay AJ., Tudur Smith C., Marson AG. |
2016 |